These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11805542)

  • 21. Single daily dose therapy with aminoglycosides.
    Nordström L; Lerner SA
    J Hosp Infect; 1991 Jun; 18 Suppl A():117-29. PubMed ID: 1679774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring.
    Slaughter RL; Cappelletty DM
    Pharmacoeconomics; 1998 Oct; 14(4):385-94. PubMed ID: 10344906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoglycoside nephrotoxicity: modeling, simulation, and control.
    Rougier F; Claude D; Maurin M; Sedoglavic A; Ducher M; Corvaisier S; Jelliffe R; Maire P
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1010-6. PubMed ID: 12604535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
    Prins JM; Weverling GJ; van Ketel RJ; Speelman P
    Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily administration of aminoglycosides.
    Bates RD; Nahata MC
    Ann Pharmacother; 1994 Jun; 28(6):757-66. PubMed ID: 7919568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do we still need the aminoglycosides?
    Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME
    Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
    Barberan J; Mensa J; Artero A; Epelde F; Rodriguez JC; Ruiz-Morales J; Calleja JL; Guerra JM; Martínez-Gil I; Giménez MJ; Granizo JJ; Aguilar L
    Rev Esp Quimioter; 2019 Feb; 32(1):22-30. PubMed ID: 30630306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cephalosporin-aminoglycoside synergistic nephrotoxicity: fact or fiction?
    Mannion JC; Bloch R; Popovich NG
    Drug Intell Clin Pharm; 1981 Apr; 15(4):248-56. PubMed ID: 7023896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aminoglycoside toxicity. Pathomechanisms, clinical management and means of prevention].
    Lautermann J; Schacht J; Jahnke K
    HNO; 2003 Apr; 51(4):344-51; quiz 352. PubMed ID: 12682739
    [No Abstract]   [Full Text] [Related]  

  • 31. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis.
    Hatala R; Dinh T; Cook DJ
    Ann Intern Med; 1996 Apr; 124(8):717-25. PubMed ID: 8633831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy.
    Leehey DJ; Braun BI; Tholl DA; Chung LS; Gross CA; Roback JA; Lentino JR
    J Am Soc Nephrol; 1993 Jul; 4(1):81-90. PubMed ID: 8400072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycosides: assessing the potential for nephrotoxicity.
    Wilson SE
    Surg Gynecol Obstet; 1990; 171 Suppl():24-30. PubMed ID: 2244292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aminoglycosides in pediatrics].
    Schaad UB
    Schweiz Med Wochenschr Suppl; 1996; 76():34S-38S. PubMed ID: 8677417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoglycoside nephrotoxicity.
    Swan SK
    Semin Nephrol; 1997 Jan; 17(1):27-33. PubMed ID: 9000547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.
    Cimino MA; Rotstein C; Slaughter RL; Emrich LJ
    Am J Med; 1987 Dec; 83(6):1091-7. PubMed ID: 3503577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():249-57. PubMed ID: 2097713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside nephrotoxicity: recent developments.
    Walker R
    N Z Med J; 1994 Feb; 107(972):54-5. PubMed ID: 8115070
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolution of aminoglycoside therapy: a single daily dose.
    Deamer RL; Dial LK
    Am Fam Physician; 1996 Apr; 53(5):1782-6. PubMed ID: 8623702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.